Natco Pharma is scouring for acquisitions in the US and Rest of the World (RoW) markets, according to its Vice-Chairman and Chief Executive Officer, Rajeev Nannapaneni. “We are working on it ...

NATCO Pharma opened sharply lower on Thursday after the company reported a 37.75% decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports.

Stock market today: Birlasoft to Natco Pharma— 155 BSE-listed shares hit 52-week low. Do you own any?(PTI) Ambika Cotton Mills, Bengal & Assam Company, Somany Ceramics, Gandhi Special Tubes ...